The cytoplasmic immunolocalization of SAV1 and MOB1A is also in line with previous reports in pancreatic carcinoma for SAV1 [17,38] and in NSCLC for MOB1A [39]. The gene discussed is MOB1A; the disease is exocrine pancreatic carcinoma.